< Terug naar vorige pagina
Onderzoeker
An Outtier
- Disciplines:Klinische trials
Affiliaties
- Translationeel Onderzoek van Gastro-enterologische Aandoeningen (TARGID) (Afdeling)
Lid
Vanaf11 mrt 2021 → Heden
Projecten
1 - 1 of 1
- Van geneesmiddelenontwikkeling tot registratie: optimalisatie van flowprocessenVanaf10 feb 2021 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 6 van 6
- Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study(2021)
Auteurs: An Outtier, Marc Ferrante, João Guedelha Sabino
Pagina's: 1136 - 1147 - Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus(2021)
Auteurs: Lucas Wauters, An Outtier, Peter Bossuyt, Marc Ferrante, Ilse Hoffman, Bram Verstockt, Séverine Vermeire
- Chronic Antibiotic-Refractory Pouchitis: Management Challenges(2021)
Auteurs: An Outtier, Marc Ferrante
Pagina's: 277 - 290 - Invasive nocardiosis, disseminated varicella zoster reactivation, and pneumocystis jiroveci pneumonia associated with tofacitinib and concomitant systemic corticosteroid use in ulcerative colitis(2020)
Auteurs: Bram Verstockt, An Outtier, João Guedelha Sabino, Eric Van Wijngaerden, Paul De Munter, Marc Ferrante, Alexander Wilmer, Séverine Vermeire
Pagina's: 2294 - 2297 - Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naive and Anti-TNF Exposed IBD Patients(2020)
Auteurs: Bram Verstockt, Erwin Dreesen, An Outtier, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pagina's: 332 - 341 - Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates(2019)
Auteurs: Bram Verstockt, Erwin Dreesen, An Outtier, Nathalie Van den Berghe, Isolde Aerden, Gert Van Assche, Ann Gils, Séverine Vermeire, Marc Ferrante
Pagina's: 864 - 872